Alexion Pharmaceuticals Inc. (ALXN) Reports Second Quarter 2013 Results  
7/25/2013 7:48:23 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Second Quarter 2013 Financial Highlights:

•Q2 2013 net product sales increased 35 percent to $370.1 million, compared to $274.7 million in Q2 2012.

•Q2 2013 GAAP net income increased 164 percent to $95.9 million, or $0.48 per share, compared to Q2 2012 GAAP net income of $36.3 million, or $0.18 per share. Q2 2012 GAAP net income included $21.8 million of tax expense related to structuring of the Enobia acquisition.

Help employers find you! Check out all the jobs and post your resume.